![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Biopix-T Gets CE Mark for COVID-19 Test and Molecular Diagnostic Platform
Biopix-T Gets CE Mark for COVID-19 Test and Molecular Diagnostic Platform
Biopix DNA Technology (Biopix-T) has received a CE mark for its COVID-19 test, COV19 qcLAMP, and for the diagnostic platform it runs on.
The portable molecular diagnostic system, dubbed Pebble qcLAMP, uses polymerase chain-reaction (PCR) technology and can be used at the point of care, the company said.
The COVID-19 kit, which uses saliva samples and delivers results within 30 minutes, was developed at the Institute of Molecular Biology and Biotechnology in Crete.
Upcoming Events
-
21Oct